EUVIMEDEUVIMED entdecken
Crossref

Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity

Byung Joo Lee, Jimin Park, Hyosook Ahn, Hyun Taek Lim

Japanese Journal of Ophthalmology · 2024

DOI: 10.1007/s10384-024-01125-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Ophthalmology, 2024. Verfasst von Byung Joo Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Myasthenia Gravis, Receptors, Cholinergic, Autoantibodies. Die Arbeit nennt 23 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To comparatively analyze the clinical characteristics of patients with ocular myasthenia gravis (OMG) referred to an ophthalmology clinic, according to anti-acetylcholine receptor antibody (AchR Ab)-seropositivity. STUDY DESIGN: Retrospective Cohort Study. METHODS: Medical records of patients with OMG who presented to a tertiary eye care center between 2003 and 2020 were retrospectively reviewed. Demographics, ophthalmologic characteristics, response to medical treatment, presence of autoimmune thyroid disease and thyroid autoantibody were compared between the AchR Ab seropositive and seronegative groups. RESULTS: A total of 130 patients with OMG were identified; among them, 46 patients (35.4%) had autoantibody against acetylcholine receptors. The mean age at symptom onset was 42.4 ± 18.9 years. There were no differences in mean age at symptom onset, gender ratio, and mean follow-up period between patients with seropositive and seronegative OMG. Graves ophthalmopathy was significantly more frequent in seronegative patients (p = 0.04), while thymic disease (p < 0.01) was more frequent in seropositive patients (p < 0.01). Among patients with seropositive OMG, 52.3% showed a good response to medical treatment, while only 31.4% of the seronegative patients were classified as good responders (p = 0.01). Thyroid dysfunction was found in 27.4% patients with OMG and the proportion of thyroid dysfunction was not different according to anti-acetylcholine receptor antibody-seropositivity. CONCLUSION: Seropositivity to acetylcholine receptor antibody is associated with a better response to medical treatment and lower risk of concomitant autoimmune thyroid disease in patients with OMG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myasthenia GravisReceptors, CholinergicAutoantibodiesHumansMaleRetrospective StudiesFemaleAdultMiddle AgedFollow-Up StudiesAgedOculomotor MusclesYoung Adult

Stichwörter der Autor:innen

Anti-acetylcholine receptor antibodyOcular myasthenia gravisSeropositive ocular myasthenia gravis

Substanzen

Receptors, CholinergicAutoantibodies

Autor:innen und Institutionen

  • Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. hyun.t.lim@gmail.com.
  • Baobab AiBIO, Incheon, Korea. hyun.t.lim@gmail.com.
  • Orthopia Eye Clinic, Seoul, Korea. hyun.t.lim@gmail.com.

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Lee, B. J., Park, J., Ahn, H., & Lim, H. T. (2024). Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity. Japanese Journal of Ophthalmology. https://doi.org/10.1007/s10384-024-01125-8

Vancouver

Lee BJ, Park J, Ahn H, Lim HT. Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity. Japanese Journal of Ophthalmology. 2024. doi:10.1007/s10384-024-01125-8

BibTeX
@article{Lee2024,
  author = {Lee, Byung Joo and Park, Jimin and Ahn, Hyosook and Lim, Hyun Taek},
  title = {Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity},
  journal = {Japanese Journal of Ophthalmology},
  year = {2024},
  doi = {10.1007/s10384-024-01125-8}
}
Kostenlos starten →